IFNAR2 and central nervous system cancer: Silginer et al. reported that silencing the gene encoding IFN alpha/beta receptor 2 (IFNAR2) leads to decreased expression of PD-L1 and major histocompatibility complex (MHC) proteins, thereby facilitating immune evasion of glioma cells (Silginer et al., 2017).